A panel of federal judges is set to hear arguments regarding the abortion drug mifepristone. The case involves whether prescribing rules for the drug should be tightened. This includes considering restrictions on access to abortion pills via telehealth subscriptions.

Further details about the case and the arguments to be presented are available from the source. The hearing will focus on the rules surrounding mifepristone, a key aspect of abortion access.

The outcome of the hearing may impact access to abortion pills, but specific details about the potential impact are not provided in the available information.